Altruist Biologics is a reliable, one-stop CDMO service provider, focusing on the development and commercial manufacturing of antibodies, fusion proteins, ADCs, cell and gene therapies, and other drugs. From cell line development to aseptic fill/finish, we are committed to supporting our clients develop affordable and high-quality biopharmaceuticals for the benefit of patients worldwide.

With our state-of-the-art, CGMP-compliant facilities and operations, Altruist Biologics offers a total capacity of 60,000 liters at its Suzhou site, which meets global regulatory standards from the NMPA, FDA, and EMA. Our new Hangzhou facility commenced partial operations with the completion of four 20,000-liter bioreactors, the first and largest of its kind in China. The site will hold a total capacity of 172KL when it becomes fully completed.

Guided by the values of “Perseverance for Altruism, Ingenuity for Sustainability”, we continuously strengthen our capabilities and quality systems in line with anticipated market and client needs to provide the most efficient and cost-effective services.